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ABSTRACT Parameters determining ionic transport numbers in transdermal iontophoresis have been characterized. The
transport number of an ion (its ability to carry charge) is key to its iontophoretic delivery or extraction across the skin. Using
small inorganic ions, the roles of molar fraction and mobility of the co- and counterions present have been demonstrated. A
direct, constant current was applied across mammalian skin in vitro. Cations were anodally delivered from either simple M1Cl
solutions (single-ion case, M1 ¼ sodium, lithium, ammonium, potassium), or binary and quaternary mixtures thereof. Transport
numbers were deduced from ion ﬂuxes. In the single-ion case, maximum cationic ﬂuxes directly related to the corresponding
ionic aqueous mobilities were found. Addition of co-ions decreased the transport numbers of all cations relative to the single-ion
case, the degree of effect depending upon the molar fraction and mobility of the species involved. With chloride as the principal
counterion competing to carry current across the skin (the in vivo situation), a maximum limit on the single or collective cation
transport number was 0.6–0.8. Overall, these results demonstrate how current ﬂowing across the skin during transdermal
iontophoresis is distributed between competing ions, and establish simple rules with which to optimize transdermal ionto-
phoretic transport.
INTRODUCTION
The stratum corneum, which is the outermost skin layer,
constitutes a formidable barrier both to the loss of tissue
water and to the entry of xenobiotics into the body. Over-
coming this barrier constitutes the major challenge in trans-
dermal drug delivery. Iontophoresis uses a mild electric current
to efﬁciently enhance and control the ﬂux of molecules across
the skin (1–4), features which have led to the recent com-
mercialization of a device to deliver lidocaine (LidoSite topical
system, Vyteris, Fairlawn, NJ) and to the imminent approval
of another containing fentanyl (E-TRANS, Alza, Mountain
View, CA). Furthermore, the symmetry of iontophoresis ren-
ders possible the noninvasive extraction of substances from
the subdermal interstitial ﬂuids. Thus, iontophoresis has also
found applications in the ﬁeld of clinical chemistry (via, for
example, the Glucowatch G2 Biographer (Cygnus, Sunny-
vale, CA)) and therapeutic drug monitoring (5–8).
The transdermal ﬂuxes of ions triggered by constant-
current iontophoresis are predicted by Faraday’s law (9,10):
J ¼ ti3 I
zi3F
(1)
where Ji, ti, and zi are the ﬂux (mol/s), transport number, and
valence of ion i, I is the current applied (in Amperes), and F
is Faraday’s constant (Coulombs/mol). The transport number
(ti) is the fraction of the total current transported by a speciﬁc
ion and expresses its efﬁciency as a charge carrier, ti¼ Ii/I. It
follows that, once the transport number is known, the feasi-
bility of its iontophoretic delivery or extraction should be
easily predictable.
The sum of the transport numbers of all the ionic species
present during iontophoresis must add up to 1 (Sti ¼ 1),
illustrating the competitive nature of electrotransport (11–
13). Thus, the iontophoretic ﬂux of the ion of interest de-
pends on the ionic composition of the solutions contacting
the outer and inner surfaces of the skin’s barrier, and it has
been suggested that the transport number may be estimated
from Eq. 2, which describes the efﬁciency of the target ion (i)
to carry current within a well stirred solution relative to the
total number (j) of ions present (10,14):
ti ¼ ci3 ui3 zi+
j
cj3 uj3 zj
(2)
where c, u, and z represent the concentration, mobility, and
charge, respectively. Eq. 2 applies to a microporous mem-
brane when the solutions bathing both sides are identical;
otherwise, a more complex combination of the external
concentrations must be constructed (14). It follows that the
transport efﬁciency of an ionic drug will depend on 1), its
physicochemical properties, which determine mobility and
concentration, and 2), the corresponding characteristics and
concentration of the co-ions and counterions present. Unfor-
tunately, the practical utility of Eq. 2 is challenging because
its rigorous application requires knowledge of ionic mobil-
ities and concentrations inside the skin. As a result, transport
numbers are usually determined experimentally from in vitro
experiments and calculations based upon Eq. 1 (15,16); these
results, however, are only valid for the speciﬁc set of exper-
imental conditions in which they are obtained.
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Nevertheless, Eq. 2 has been used to predict the ionto-
phoretic transport of two competing cations (10), and to dem-
onstrate that their molar fractions in the anode solution are
critical (an observation conﬁrmed later for lidocaine trans-
port in the presence of varying concentrations of Na1 (16)).
However, the quantitative application of the model is limited,
because it applies only to neutral and homogenous mem-
branes and requires the introduction of empirical factors to
correct for ionic interactions.
Transdermal iontophoretic transport has also been described
using Nernst-Planck electrodiffusion theory. In particular,
the ‘‘electroneutrality’’ approximation has been applied to the
case of a 1:1 electrolyte transporting through an uncharged
membrane (17). In this case, the transport number of a mono-
valent species M1, present as its chloride salt, when normal
saline alone ﬁlls the subdermal compartment, is given by
tM ¼ DMðDM1DClÞ: (3)
DM and DCl are the diffusion coefﬁcients of M
1 and Cl in
the membrane. The efﬁciency of electrotransport is largely
determined, therefore, by the ratio of the diffusivities of the
target ion and the counterion; the concentration of M1 does
not appear in the equation as it is the only cation in the anodal
solution. On the contrary, in the presence of competing cations,
the transport number of M1 becomes a strong function of its
concentration. The validity of this approach has been dem-
onstrated qualitatively for constant-current iontophoresis
(18–20); again, however, its use as a predictive tool is limited
because absolute values of DM and DCl are unknown.
Another approach has involved an attempt to relate ion-
tophoretic ﬂux to different physicochemical properties, such
as speciﬁc conductivity (21,22). However, the latter is a func-
tion of both the concentration and mobility of all the ions
present in the electrode chamber (both anions and cations)
and this limits its value as a predictor of the transport of a
single ion. Although it has been suggested that this problem
may be circumvented by the determination of ionic mobil-
ities from equivalent conductance at inﬁnite dilution (19), the
hypothesis has not yet been tested.
In summary, the available models are qualitatively useful
but restricted in practice to the transport of two competing
co-ions through a homogenous and uncharged membrane.
However, it is known that the skin, under normal circum-
stances, is a negatively charged, cation-permselective mem-
brane. Under the inﬂuence of an electric ﬁeld, therefore, a
convective, electroosmotic ﬂow proceeds in the anode-to-
cathode direction (23,24), supplementing cationic transport
during iontophoresis and allowing the enhanced transport of
neutral polar substances such as glucose or mannitol (25,26).
Furthermore, iontophoretic transport across the skin takes place
via both intercellular and appendageal routes (27). Describ-
ing and integrating this additional complexity into a single
model, and then demonstrating its validity, are challenging
objectives yet to be achieved, such that it is not possible at
this time to predict the complex relations that determine trans-
port numbers in a multi-ionic environment. Still, it is exactly
this challenge with which one is confronted in the develop-
ment of pharmaceutical formulations that typically require,
in addition to the active species, excipients such as buffers, pre-
servatives, and other components. Although charged additives
will clearly decrease drug transport efﬁciency, the degree to
which the transport is reduced is not easily predicted. In
reverse iontophoresis, the presence of endogenous ions limits
the extraction efﬁciency of the analyte of interest. In addi-
tion, for the approach to be useful, the analyte transport
number must depend directly on its concentration in the
interstitial ﬂuid, in which high concentrations of sodium and
chloride and a complex mixture of other endogenous ions are
present. Nevertheless, this complexity has been taken advan-
tage of in the development of a noninvasive procedure to
calibrate reverse iontophoretic devices: using a so-called
‘‘internal standard’’, the extraction of the analyte of interest
is normalized to that of a second substance, the subdermal
concentration of which is known and ﬁxed (26,28). This
method has been used to noninvasively predict lithiemia in
bipolar patients, with sodium acting as the internal standard
(29). For this strategy to work, the internal standard must be
extracted at a constant iontophoretic ﬂux (i.e., its transport
number must be invariable). Although it is known that the
systemic level of Na1 varies only between quite tight limits,
the applicability of the internal-standard hypothesis requires
validation that the reverse iontophoretic ﬂux of Na1 is not
inﬂuenced signiﬁcantly by variations in the levels of other
ions in the interstitial ﬂuid milieu.
Thus, the aims of this work are to elucidate the criteria that
determine the iontophoretic transport of ions across the skin,
and optimize the delivery/extraction of target species. In
particular, the manner in which the transport of charge is
distributed among competing co-ions has been investigated.
For the moment, the skin itself is treated as a ‘‘black box’’,
without imposing speciﬁc attributes to either the membrane
or the pathway. Instead, the iontophoretic transport of a series
of cations has been systematically evaluated. In a ﬁrst step,
the electromigration of monovalent inorganic cations is stud-
ied and their transport efﬁciency as single-ion carriers in the
presence of chloride counterions is characterized. Next, co-ion
competition is investigated using binary cation mixtures. Fi-
nally, quaternary mixtures are considered and the distribution of
charge-carrying responsibility in complex and changing ionic
environments is revealed.
MATERIALS AND METHODS
Materials
Sodium chloride, lithium chloride, ammonium chloride, and magnesium
chloride were obtained from Fluka (St. Quentin Fallavier, France). Potas-
sium chloride was purchased from Sigma-Aldrich (St. Quentin Fallavier,
France). Deionized water was used for preparing all the solutions (resistivity
.18 MOhm/cm2).
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Skin preparation
Porcine ears were obtained fresh from the local slaughterhouse (Annecy,
France) and cleaned under cold running water. The tissue was dermatomed
to a thickness of 750 mm (Zimmer Air Dermatome, Dover, Ohio) and cut
into small squares (9 cm2) which were wrapped individually in Paraﬁlm and
maintained at 20C for no longer than 1 month before use. Each experi-
ment used skin from at least four different pigs.
Iontophoresis
The skin was clamped between the two halves of side-by-side diffusion cells
(transport area 0.78 cm2) with the stratum corneum facing the anodal cham-
ber. Three to nine replicates were performed for each condition. Both the
donor and the receptor chambers were ﬁlled with deionized water during two
equilibrating periods of 30 min. Subsequently, the cathodal compartment was
ﬁlled with 3 mL of a 5-mM MgCl2 solution. This solution was chosen to
provide a source of chloride which is the principal endogenous counterion
limiting iontophoretic cation delivery. MgCl2 was chosen rather than a phys-
iological concentration of NaCl because the latter would have made the
electrotransport of Na1 from the anode very difﬁcult to measure. The con-
centration of MgCl2 was only 5 mM to minimize interference of the Mg
21
peak with those of the other cations in the ion chromatogram. The anodal
chamber was ﬁlled (3 mL) with the respective chloride salt(s) of the cation(s)
tested in each experiment (see below). Chloride salts were used because they
provide the chloride ions required for the anodal electrochemistry. Constant
direct current (0.4 mA) was applied for 6 h via Ag/AgCl electrodes con-
nected to a power supply (Kepco, MB Electronique, Bron, France). The
solutions in the electrode chambers were magnetically stirred throughout the
experiment.
Experimental design
Single ions
The anodal solution was a 100-mM chloride salt of one of the four cations
tested (Na1, NH4
1, K1, and Li1). These experiments examined the ‘‘single-
carrier’’ or ‘‘single-ion’’ situation, i.e., they determined the capability of each
cation to compete for charge transport against chloride counterions. The com-
position of both electrode chambers (Table 1) was kept constant throughout
the experiment (6 h). The entire anodal and cathodal solutions were sampled
every hour and the electrode chambers reﬁlled with fresh solutions. This
procedure avoided artifacts due to depletion of the ionic content.
Binary combinations
These experiments (Table 1) tested the ability of K1, NH4
1, and Li1 to
compete with Na1. The ﬁrst series of studies (B.C125, B.C150, and
B.C1100) investigated a ﬁxed level of sodium (100 mM) competing with
progressively higher concentrations of each co-ion (25, 50, and 100 mM).
The sodium molar fraction (XNa
1 ) was decreased therefore from 0.8 to 0.5 in
these measurements. In a second set of experiments (B.C120 and B.C1100),
on the other hand, a constant molar ratio of the two was considered (either
100:100 mM or 20:20 mM). The composition of both electrode chambers
was again kept constant throughout the experiments. The entire anodal and
cathodal solutions were sampled every hour and the electrode chambers reﬁlled
with fresh solutions.
Multiple-ion combinations
The aim of these experiments (Table 2) was to study how the charge ﬂowing
across the skin during iontophoresis is distributed in more complex sit-
uations. ExperimentM.1 employed an anodal formulation containing 50mM
of each cation (Li1, Na1, NH4
1, and K1) chloride. The remaining experi-
ments evaluated how the cations’ transport numbers were modiﬁed by changes
in the ionic composition of the donor formulation. Iontophoresis was initi-
ated with one of the anodal compositions in Table 2 and samples were taken
hourly for 3 h. The donor solution was then replaced as indicated in Table 2.
Subsequently, samples were taken every half-hour during a second 3-h period
of iontophoresis. Experiments M.2 and M.3 examined the impact of a sharp
decrease in sodium concentration on the ﬂuxes of the competing co-ions.
Finally, experiment M.4 considered the effect of simultaneously increasing the
concentration of ammonium and potassium.
Sample analysis
Lithium, sodium, potassium, and ammonium ions were assayed by ion
chromatography on a Dionex ion chromatograph 600 system (Dionex,
Sunnyvale, CA) equipped with a gradient pump, a thermal compartment, and
an electrochemical detector. Separation was achieved with a cation-exchange
column preceded by a guard column through which a 25-mM methanesulfonic
TABLE 1 Composition of the anodal solutions for the
single-ion and binary combination experiments
Experiment code Carrier ion(s) (mM)
Single-ion S.C1 (n)
S.Li1 (6) Li1 (100)
S.Na1 (9) Na1 (100)
S.NH4
1 (3) NH4
1 (100)
S.K1 (6) K1 (100)
Binary combination B.C1 (mM) (n)
B.Li1 (25) (7) C1 (25)
B.NH4
1 (25) (6) Na1 (100)
B.K1 (25) (6) –
B.Li1 (50) (7) C1 (50)
B.NH4
1 (50) (6) Na1 (100)
B.K1 (50) (5) –
B.Li1 (100) (7) C1 (100)
B.NH4
1 (100) (7) Na1 (100)
B.K1 (100) (6) –
B.Li1 (20) (5) C1 (20)
B.K1 (20) (3) Na1 (20)
In all experiments, the cathodal solution was 5 mM MgCl2 (i.e., 10 mM
Cl).
TABLE 2 Composition of the anodal solutions for the
multiple-ion combination experiments
Experiment code (n) Time (min) Carrier ions (mM)
M.1 (6) 0–300
Li1 (50), K1 (50)
NH4
1 (50), Na1 (50)
M.2 (6)
0–180
Li1 (50), K1 (25)
NH4
1 (25), Na1 (100)
180–360
Li1 (50), K1 (25)
NH4
1 (25), Na1 (25)
M.3 (5)
0–180
Li1 (25), K1 (50)
NH4
1 (25), Na1 (100)
180–360
Li1 (25), K1 (50)
NH4
1 (25), Na1 (25)
M.4 (6)
0–180
Li1 (25), K1 (50)
NH4
1 (25), Na1 (25)
180–360
Li1 (25), K1 (100)
NH4
1 (35), Na1 (25)
In all experiments, the cathodal solution was 5 mMMgCl2 (i.e., 10 mM Cl
).
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acid mobile phase was perfused. Quantiﬁcation was performed in the sup-
pressed conductivity mode; the electric current applied to the suppressor was 88
mA. A calibration was carried out with at least ﬁve standards for Li1, Na1,
NH4
1, and K1.
Data analysis
Transport numbers were determined for each sampling period via Eq. 1. The
values reported correspond to the mean 6 SD of 3–9 replicates. Statistical
analysis used Prism 4 (GraphPad Software, San Diego, CA). One- and two-
way ANOVAs followed by the corresponding Tukey and Bonferroni tests
were used to analyze the data from single-ion and binary-cation experiments.
The level of statistical signiﬁcance was ﬁxed at p , 0.05. All linear regres-
sion procedures were followed by the corresponding ANOVAs to test the
signiﬁcance of the regression.
RESULTS AND DISCUSSION
As described above, no buffer was used in any of the experi-
ments in this study so as to avoid the presence of additional
competing species. The pH of the subdermal receptor solu-
tion was 6, whereas that of the donor varied between 5 and 6,
depending on the ionic composition. The dominant mecha-
nism of iontophoretic transport for the small inorganic cat-
ions examined here is electromigration which is generally
less sensitive to pH than electroosmosis (30). Indeed, when
the effect of pH was assessed using two 10-mM NaCl donor
solutions, it was found that the Na1 transport numbers at pH
5 and 7 were 0.59 6 0.01 and 0.64 6 0.03, respectively.
Because all experiments reported here employed the same
cathodal electrolyte (5 mM MgCl2, pH ;6), the small pH
variations in the donor solutions were considered insufﬁcient
to signiﬁcantly modify cation transport from the anode across
the skin.
Single ions
The single carrier condition is optimal for iontophoretic drug
delivery. Above all, this situation ensures maximum drug
ﬂux (i.e., maximum transport number) since the competition
to carry the current is limited to endogenous counterions
beneath the skin. Second, Eq. 3 (17) predicts that the ion’s
transport number under these conditions (ti) is independent
of applied concentration. From a practical point of view, this
allows maximum ﬂux to be achieved at low ‘‘loading’’, a
convenient feature for the delivery of expensive drugs such as
peptides. The validity of this prediction has been demon-
strated in vitro for lidocaine (tLidocaine
o ¼ 0.19), hydro-
morphone (tHydromorphone
o ¼ 0.18), and for ropinirole both in
vitro (tRopinirole
o ¼ 0.10) and in vivo (tRopinirioleo ¼ 0.15) (16,18–
20). Because ti determines the feasibility of drug delivery by
iontophoresis, it would be extremely useful to predict this
parameter from simple physicochemical properties. In this
ﬁrst series of experiments; the ti of lithium, sodium, potas-
sium, and ammonium were determined with chloride as the
competing counterion. The results are shown in Table 3 and
are compared to the corresponding aqueous transport numbers
(31). The latter clearly reﬂect the mobility of each cation rela-
tive to that of chloride (uCl
 ¼ 7.9 3 104 cm2s1V1). As
expected, the aqueous mobilities of the cations are related
to hydrodynamic radius (as opposed to atomic or molecular
weight, or to ionic radius (32)). Small ions, of course, are ex-
tensively solvated and, hence, the effective size of Li1, for
example, is greater than those of K1 and NH4
1.
The sodium and potassium transport numbers are sim-
ilar to those reported previously (;0.5–0.6) for human and
pig skin (15,33,34); the differences are attributable to the
different experimental conditions (buffers, pH) and methods
employed. Cationic transport numbers across skin are signiﬁ-
cantly greater than those in aqueous solution because of the
membrane’s net negative charge (34). From a practical point
of view, this means that iontophoresis more efﬁciently
delivers cationic drugs, a deduction well supported by experi-
mental observation (35,36).
The results of these experiments deﬁne an upper limit for
drug delivery by iontophoresis; that is, no drug can do better
than these small, inorganic cations when competing with
endogenous chloride (concentration.100 mM) transporting
current in the opposite direction. Lithium, therefore, would
be the best drug candidate for iontophoretic delivery (it is
presently administered orally to treat bipolar disorder) and its
transport number in Table 3 may be considered as an upper
TABLE 3 Cation transport numbers in water and in the skin during transdermal iontophoresis
Water Skin
Cation
Atomic
weight
Ionic
radius* (A˚)
Hydrodynamic
radiusy (A˚)
Mobility*
(104 cm2s1V1) tiH2Oz
ti, SC1 6 SD
(Expt. S.C1)
ti, M1 6 SD
(Expt. M.1)
Li1 6 0.060 1.73 4.01 0.33 0.54 6 0.06§(a) 0.13 6 0.01§(b,c)
Na1 23 0.095 1.67 5.19 0.39 0.59 6 0.06{ 0.18 6 0.01§(b)
NH4
1 18 0.133 1.14 7.60 0.49 0.77 6 0.19§{(a) 0.22 6 0.02§(b)
K1 39 0.143 1.14 7.62 0.49 0.70 6 0.15 0.22 6 0.01§(c)
Values were deduced from the results of single-carrier and quaternary combination donor formulations.
*Ionic radius and mobility data were taken from Atkins (32).
yHydrodynamic radius calculated from ionic mobility (32).
zThe transport numbers in water were taken from Falk (31).
§(a,b,c)Values signiﬁcantly different (one-way ANOVA, Tukey test, p , 0.01).
{Values signiﬁcantly different (one-way ANOVA, Tukey test, p , 0.05).
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limit for the charge-carrying efﬁciency of cationic drugs. All
other drugs are larger and less mobile than lithium, and will
therefore transport ,54% of the charge when confronted
with the physiological concentration of subdermal chloride.
It is worth noting that the relative order of cation transport
numbers in water and through the skin is similar: tLi
o , tNa
o ,
tK
o  tNH4o , with the values for lithium being signiﬁcantly less
than those of potassium and ammonium (Table 3). As
discussed previously, the ti
o has been suggested to be a func-
tion of the diffusivities of the cation and its counterion (17).
Equally, the Einstein relationship predicts a direct propor-
tionality between diffusivity and mobility (D ¼ uiRT/ziF)
(32). However, it is difﬁcult to measure ionic diffusivities or
mobilities within the skin (37), begging the question,
therefore, as to whether values measured in water may be
used to predict the corresponding transport number in skin
for the single carrier situation. Although the results in Table
3 are consistent with this idea, and the much lower mobil-
ities of ropinirole and lidocaine (1.6 3 104 cm2s-1V-1 and
1.5 3 104 cm2s1V1, respectively) correlate with their
signiﬁcantly smaller transport numbers, the hypothesis re-
quires a larger data set before it can be conﬁrmed or refuted.
Binary combinations
The goal of these experiments was to study co-ion compe-
tition in the simplest system possible: i.e., two cations (one
of which was always sodium) competing against subdermal
chloride. Sodium ion competition with other cations is
relevant because: 1), sodium (as saline) is a very common addi-
tive to drug formulations (as a buffer component, stabilizing
agent, etc.), and 2), in reverse iontophoresis, the use of so-
dium as an internal standard requires that its iontophoretic
ﬂux remains constant despite variation in the ionic compo-
sition of the interstitial ﬂuid.
According to Eq. 2, the mobility and concentration inside
the skin are the principal factors that determine the transport
number of monovalent ions. For hydromorphone and lido-
caine (16,18), molar fraction is a better predictor of ionto-
phoretic ﬂux than the nominal concentration, as it reﬂects the
drug level relative to the total concentration of cations present.
On the other hand, the iontophoretic ﬂux of ropinirole
revealed more complicated behavior when its concentration
and that of competing sodium ions were changed in parallel
(19). One series of experiments performed with monovalent
inorganic cations (Table 1: B.C125, B.C150, and B.C1100)
involved a constant concentration of sodium ions competing
with a progressively higher level of a second cation (Li1,
K1, or NH4
1). As a result, the sodium molar fraction decreased
from 0.8 to 0.5, whereas that of the competitor increased
from 0.2 to 0.5. In experiments B.C120 and B.C1100 the
two competing cations were introduced at the same milli-
molar concentrations, 20:20 and 100:100, such that their
molar fractions were kept constant. The results (Table 4 and
Figs. 1 and 2) were as follows:
a. Both molar fraction and the identity of the competitor ion
were signiﬁcant factors determining the transport number
(two-way ANOVA, p, 0.0001). The transport number of
lithium was signiﬁcantly smaller (p, 0.001) than those of
potassium and ammonium under equivalent conditions,
presumably due to lithium’s lower mobility. Practically
speaking, this means that the introduction of sodium ions
into an iontophoretic formulation of a cationic drug will
have an impact dependent upon the drug’s mobility; that
is, the drug’s transport number will be reduced, and the
decrease will be more important for the least mobile drugs.
Thus, whenever practical, formulation additives should be
selected from low-mobility, and ideally uncharged, species
that are introduced at the lowest suitable concentration
possible.
TABLE 4 Individual and total cation transport numbers
deduced from the binary cation experiments
Experiment tC1 tNa
1 +tCation
B.Li1 (25) 0.09 6 0.01 0.46 6 0.07 0.55 6 0.08
B.K1 (25) 0.17 6 0.02 0.46 6 0.03 0.60 6 0.05
B.NH4
1 (25) 0.21 6 0.01 0.50 6 0.02 0.72 6 0.02
B.Li1 (50) 0.18 6 0.01 0.48 6 0.05 0.62 6 0.05
B.K1 (50) 0.25 6 0.04 0.45 6 0.07 0.70 6 0.06
B.NH4
1 (50) 0.29 6 0.06 0.46 6 0.08 0.75 6 0.11
B.Li1 (100) 0.26 6 0.05 0.33 6 0.02 0.58 6 0.07
B.K1 (100) 0.39 6 0.05 0.34 6 0.08 0.71 6 0.10
B.NH4
1 (100) 0.37 6 0.02 0.34 6 0.01 0.71 6 0.02
B.Li1 (20) 0.21 6 0.03 0.30 6 0.03 0.51 6 0.06
B.K1 (20) 0.44 6 0.02 0.31 6 0.02 0.75 6 0.03
Values are given as mean 6 SD for 3–9 experiments. Numbers in square
brackets in ﬁrst column signify millimolar concentration of co-ion.
FIGURE 1 Co-ion (C1) transport number (tC1) as a function of its molar
fraction in binary cation experiments (B.C125, B.C150, and B.C1100).
Lines of linear regression are drawn through the data, which are presented as
the mean 6 SD (n $ 5). For clarity, although the upper and lower 95%
conﬁdence interval is shown for lithium, only the upper and lower 95%
conﬁdence intervals, respectively, are shown for ammonium and potassium.
A two-way ANOVA indicates that both the nature and the molar fraction of
C1 are determinant factors of tC1. The regression equations were tLi1 ¼
0.025 (60.02) 1 0.581 (60.05) XLi, r2 ¼ 0.86; tK1 ¼ 0.014 (60.03) 1
0.752 (60.08) XK, r
2 ¼ 0.85; and tNH41 ¼ 0.117 (60.02) 1 0.514 (60.06)
XNH4, r
2 ¼ 0.82. The three regressions were signiﬁcant (p , 0.001) and the
values in brackets correspond to the standard errors of the statistics.
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b. The experiments B.C125, B.C150, and B.C1100 (Table
4 and Fig. 1) show that the transport numbers of Li1,
K1, and NH4
1 increased with concentration, whether ex-
pressed in molar units or as a molar fraction. Comparison
of the results from experiments B.C120 and B.C1100
(Table 4) showed that molar fraction is a better predictor
of transport number than molarity, because it expresses
the level of the cation of interest with respect to the total
ionic background. The results reported here agree with
those obtained previously for lidocaine and hydro-
morphone (16,18) and, interestingly, a similar relation-
ship can be deduced from data published in 1929 from
experiments examining the competition between sodium
and potassium ions in aqueous solutions (31).
c. Another relevant question is the manner in which the
transport number of a drug increases with concentration
in the formulation. Clearly, as the sum of transport num-
bers of the ions must add up to 1, there is a maximum lim-
it for the ﬂux (i.e., the ti) of each species. Fig. 1 indicates
linear relationships between the transport numbers of
Li1, K1, and NH4
1 and their respective molar fractions.
The ion’s transport number in the single-ion situation can
be predicted from these regression equations by setting
the molar fraction equal to 1. The values obtained for
Li1, K1, and NH4
1 are 0.56, 0.76, and 0.63, respectively,
in excellent agreement with those measured experimen-
tally in the single-ion experiments (Table 3). Finally, it is
noted that the gradient of the regression in Fig. 1 for
lithium is signiﬁcantly lower (p , 0.04) than that for
potassium, a ﬁnding due, perhaps, to the different mobil-
ities of these ions. Similarly, for lidocaine, under com-
parable experimental conditions, the gradient was 0.18
(16). These results suggest that the transport numbers of
more mobile drugs across the skin increase more quickly
with molar fraction (that is, in accord with Eq. 3, it is not
simply the relative concentrations of the ions that are
important, but also their mobilities: smaller, more mobile
ions will ‘‘grab’’ a larger fraction of the charge). The
principle has also been demonstrated in aqueous solu-
tions where regression slopes for Na1 and K1 (31) were
0.35 and 0.47, respectively. Nevertheless, further re-
search with more compounds is required to conﬁrm this
hypothesis.
d. The transport number of Na1 did not decrease signiﬁ-
cantly until its molar fraction was reduced to 0.5; the
decrease appeared to be independent of the nature of the
competitor (Fig. 2 and Table 4), a result conﬁrmed by a
two-way ANOVA on the effect of sodium concentration
and competitor ion on the sodium transport number. The
identity of the competitor was not important, whereas the
sodium transport number showed a signiﬁcant reduction
only at the lowest molar fraction considered (p , 0.001).
These results are relevant to the use of sodium as an
internal standard in reverse iontophoresis. Sodium con-
centration in plasma varies from 135 to 145 mM; other
cations present at the millimolar level are potassium
(3.4–4.8 mM), calcium (2.1–2.6 mM, 50–60% ionized
and partially bound to proteins), and magnesium (0.68–
0.88) (38). Other cations are found at the micro or
nanomolar level. Thus, under normal physiological cir-
cumstances, the sodium molar fraction in blood should
be $0.94. An increase in potassium to 10 mM (the
highest value reported for a severe hyperkalemia (38))
would only decrease the sodium molar fraction to 0.91.
Therefore, the results reported are consistent with pre-
vious in vitro and in vivo observations on the constancy
of sodium iontophoretic ﬂux and its role as an internal
standard (26,29,39). In fact sodium molar fraction would
have to decrease to levels incompatible with life before
the iontophoretic ﬂux of this ion is signiﬁcantly modi-
ﬁed. That is, even though Na1 mobility is less than those
of K1 and NH4
1, the impact of this difference is too
small to be observed experimentally until the concentra-
tions of the ions become (nonphysiologically) similar.
e. A ﬁnal observation is that the sum of the cation trans-
port numbers is quite constant (Table 4) despite the large
variations studied in the total concentration of these
species. Experiments B.C120 and B.C1100 are partic-
ular examples: a ﬁvefold increase in cation concentration
(40–200 mM) had a minimal effect on the sum of the cat-
ion transport numbers. Interestingly, in classic experi-
ments with binary donors in water, the maximum sum of
Na1 and K1 transport numbers was 0.4 (31). Not unex-
pectedly, the presence of a cation-permselective mem-
brane, such as the skin, results in an overall cation
transport number that is higher (0.5–0.8). This effect is
noteworthy, as the chloride concentration employed in
this work (10 mM) was only 1/4 to 1/20 of the total
cation concentration. However, it must be remembered
that the single-ion situation applied to chloride here and
that its transport was predicted (17) to be dependent only
on its diffusivity relative to that of the cations present (for
FIGURE 2 Sodium transport number (tNa
1 ) as a function of its molar
fraction in the binary cation experiments (B.C125, B.C150, and B.C1100).
The data are presented as the mean 6 SD (n $ 5). A two-way ANOVA
indicates that the sodium molar fraction is the only determinant factor
of tNa
1 .
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example, a lower total cationic transport number is
observed in the binary experiments with lithium and
sodium compared to the potassium/sodium couple (p ,
0.01)). Further, although the prediction was developed
for a 1:1 electrolyte, the results from this work suggest
that the theory applies to more complex situations; that
is, whereas the donor solutions were always 1:1 electro-
lytes, the receiver phase contained MgCl2, which is a 1:2
electrolyte. Thus, although there is no traceable tie be-
tween the theory cited and the experimental conditions,
the results obtained are nevertheless well predicted by the
relatively simplistic model. From a practical point of
view, these data imply that even the best combination of
competing cations in an iontophoretic vehicle will not
result in a total cation transport number of .0.75, setting
a clear upper limit on the iontophoretic delivery efﬁ-
ciency of cationic drugs.
Multiple-ion combinations
It is evident that molar fraction and mobility are the key
determinants of cation transport numbers in simple binary
mixtures, but ‘‘real-world’’ iontophoretic vehicles may be
more complex, incorporating both background electrolyte
and buffer constituents, for example. Although the effect of
sodium concentration on the iontophoretic transport of a
drug has been frequently reported (11,13,16,40), the impact
of a complex background electrolyte has received much less
attention. Thus, the rational development of iontophoretic
vehicles is complex. The last component of this study there-
fore examined how transport numbers are determined in com-
plex ionic environments and how they may be modiﬁed by
manipulation of the formulation.
Fixed-concentration experiments
The ﬁrst experiment (Table 2, M.1) determined the distribu-
tion of charge transport among the four cations when present
at the same concentration. The transport numbers were cor-
related with aqueous mobilities and were consistent with
the values measured in the single-ion situation (Table 3). It
follows that, when present at equal concentrations, the more
mobile cations will transport a higher fraction of the charge,
and that transport numbers determined in the single-ion
situation are good predictors of the charge distribution in
complex ionic environments. Once again, it is noted that the
sum of the cation transport numbers is;0.75 (see preceding
section).
Stepwise concentration-change experiments
The next experiments (Table 3, M.2 and M.3) examined the
situation in which the sodium concentration in the anode
formulation, initially at 100 mM, was subsequently lowered
in a step change to 25 mM. The idea was to replicate, in part,
the optimization of an iontophoretic vehicle. The goal was
to evaluate how the initial sodium transport number was
‘‘distributed’’ among the other cations, and to determine
which of the co-ions eventually beneﬁted most from the
reduced Na1molar fraction. The two experiments differed in
terms of the mobility of the second-most concentrated (50
mM) cation initially present: lithium (M.2) or potassium
(M.3). The following observations (Table 5 and Fig. 3) are
worthy of comment. Firstly, sodium and ammonium trans-
port numbers changed in a similar fashion in both experi-
ments, independent of the levels of potassium and lithium.
The charge ‘‘captured’’ by sodium and ammonium is prin-
cipally determined by their molar fractions in the formula-
tion; these levels were the same in both experiments and
were unaffected by the relative amounts of potassium and
lithium. Second, the transport numbers of ammonium and
potassium, which have equivalent mobilities in water, clearly
reﬂected their relative concentrations in the formulation.
Hence, the potassium transport number was about double
that of ammonium transport numbers in M.3, whereas the
two were very similar in M.2. On the other hand, lithium,
which is less mobile than potassium, captured signiﬁcantly
less charge than potassium even when the two cations were
present in equal concentrations.
In experiment M.4, two cations of similar mobility are
simultaneously increased, potassium from 50 to 100 mM,
and ammonium from 25 to 35 mM. Transport numbers in the
ﬁrst step agreed with results already discussed; i.e., the roles
of mobility and concentration were apparent. Lithium and
sodium transport numbers in the second step decreased as
TABLE 5 Individual and total cation transport numbers
deduced from the multiple-ion experiments
M.2
ti (mean 6 SD)
% change0–180 min 180–360 min
Li1 0.11 6 0.01 0.18 6 0.01 64.8 6 4.0
Na1 0.34 6 0.02 0.16 6 0.01 53.9 6 1.5
K1 0.11 6 0.01 0.19 6 0.01 58.7 6 10.1
NH4
1 0.09 6 0.01 0.15 6 0.01 53.8 6 7.0
+ti1 0.66 6 0.04 0.68 6 0.04 –
M.3
ti (mean 6 SD)
% change0–180 min 180–360 min
Li1 0.10 6 0 .01 0.16 6 0.01 56.0 6 8.6
Na1 0.31 6 0.03 0.17 6 0.01 46.9 6 2.0
K1 0.21 6 0.02 0.32 6 0.01 49.3 6 8.0
NH4
1 0.12 6 0.02 0.17 6 0.01 38.8 6 11.3
+ti1 0.74 6 0.06 0.81 6 0.02 –
M.4
ti (mean 6 SD)
% change0–180 min 180–360 min
Li1 0.08 6 0 .01 0.05 6 0.01 30.1 6 3.2
Na1 0.15 6 0.01 0.11 6 0.01 25.6 6 2.1
K1 0.33 6 0.02 0.42 6 0.02 30.3 6 4.1
NH4
1 0.18 6 0.02 0.14 6 0.02 20.7 6 5.5
+ti1 0.74 6 0.05 0.73 6 0.06 –
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expected. Surprisingly, ammonium transport numbers also
decreased despite its presence at a higher concentration. This
experiment underlined the critical role of molar fraction, the
value of which, for NH4
1, slightly decreased from 0.2 to 0.19
due to the more important increase in potassium. At a
practical level, this ﬁnding suggests that an increased drug
ﬂux (i.e., a higher transport number) can be achieved by
increasing the molar fraction of the drug without necessarily
raising the molar concentration. Overall, these quaternary
donor experiments convey the messages that 1), at equal
concentration, transport numbers will align themselves as a
function of the co-ions’ mobilities, and 2), at equal mo-
bilities, the transport numbers are directly proportional to
molar fraction.
The degree to which the transport number of each cation is
modiﬁed when the donor solution is altered (% change), may
be calculated from
% change ¼ 1003 ðtfinal  tinitialÞ
tinitial
: (4)
For sodium, the% change in experimentsM.2 andM.3was
54 (6 1.5)% and 47 (6 2)%, respectively (Table 5). The
corresponding changes in the transport numbers of Li1, K1,
and NH4
1 in these experiments were relatively constant
(falling in the ranges of 53–65% in experiment M.2 and 39–
56% in experiment M.3). In experiment M.4, the % change in
tK1was 30 (6 4)%, whereas those of the other cations fell by
an amount in the range of 21–30%. It follows that the relative
changes of all cations under equivalent conditions were
relatively constant for a given change in the formulation.
Finally, the sum of the cation transport numbers ranges
between 0.65 and 0.85 for the six donor compositions
examined over a total ionic concentration from 125 to 200
mM. That is, a total cationic transport number is conserved in
a manner consistent with M.1 and binary mixture experi-
ments. Overall, these experiments conﬁrm that 1), cationic
delivery by iontophoresis will always be restricted by
endogenous chloride efﬂux, and 2), a maximum efﬁciency
of 60–80% can be ﬁrmly established for positively charged
drugs.
CONCLUSIONS
The transdermal iontophoresis experiments reported here
support the following conclusions: 1), the single-ion situa-
tion allows maximal transport efﬁciency, which is correlated
with aqueous mobility; 2), the presence of sodium as a
competing species decreases cation transport numbers in a
manner related to the relative aqueous mobilities and molar
fractions in the anodal solution; 3), molar fraction, rather
than absolute concentration, should be optimized for formu-
lation purposes; 4), the reverse iontophoretic ﬂux of sodium
under physiological conditions will be constant, supporting
the role of sodium as an internal standard; 5), the transport
numbers of all co-ions are modiﬁed to the same extent when
the ionic composition of the donor formulation is modiﬁed;
and 6), despite widely different total cation concentrations at
the anode, the sum of cation transport numbers maximizes at
;0.65–0.81, and it follows that competition from subdermal
chloride cannot be eliminated via changes in the iontopho-
retic vehicle—that is, the efﬁciency of cationic delivery is
limited.
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